[REGN] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
06-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- -2.96%
YoY- 78.55%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 4,951,700 3,452,800 5,138,500 2,528,700 2,422,900 2,294,000 1,952,000 85.68%
PBT 2,503,400 1,816,600 3,752,800 1,253,000 1,224,600 998,300 918,900 94.70%
Tax 274,400 184,400 653,900 137,800 75,400 156,200 21,600 441.92%
NP 2,229,000 1,632,200 3,098,900 1,115,200 1,149,200 842,100 897,300 83.11%
Tax Rate -10.96% -10.15% -17.42% -11.00% -6.16% -15.65% -2.35% -
Total Cost 2,722,700 1,820,600 2,039,600 1,413,500 1,273,700 1,451,900 1,054,700 87.85%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin 45.01 47.27 60.31 44.10 47.43 36.71 45.97 -1.39%
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS 20.99 15.37 29.51 10.58 10.90 7.98 8.19 86.95%
EPS Diluted 19.69 14.33 27.97 10.09 10.24 7.39 7.61 88.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.